Management of Worsening Renal Function in Patients on Corticosteroid Therapy

Initial Assessment and Management

The American College of Cardiology and other guideline societies recommend immediately discontinuing any concurrent NSAIDs if a patient develops worsening renal function while on corticosteroid therapy, as this combination significantly impairs renal function 2, 3, 4
The European Society of Cardiology suggests that stopping all NSAIDs immediately is crucial, as they can cause reversible acute renal failure in high-risk patients by inhibiting prostaglandin-dependent renal blood flow 2, 3, 4

The National Kidney Foundation recommends monitoring serum creatinine weekly during corticosteroid treatment in patients with any degree of renal impairment, and checking serum potassium levels concurrently, as corticosteroids can affect electrolyte balance 1, 5
The American Society of Nephrology suggests assessing for volume status and blood pressure control, as fluid retention occurs in virtually all patients exposed to corticosteroids 1, 5

The American College of Rheumatology states that prednisone does not require dose adjustment based on renal function, as it undergoes hepatic metabolism with minimal renal excretion, allowing standard dosing protocols even in CKD stage 5 1
The National Kidney Foundation recommends continuing the corticosteroid regimen appropriate for the underlying disease without modification for renal dysfunction alone, unless other etiologies are ruled out and corticosteroids are being used for immune-mediated nephritis 1, 5

The American Society of Clinical Oncology suggests following a structured approach based on severity of renal impairment, including temporarily holding the underlying immunotherapy if applicable, but continuing corticosteroids for Grade 1 creatinine elevation 5
The European Renal Association recommends consulting nephrology for Grade 2 creatinine elevation, and considering increasing to 0.5-1 mg/kg/day prednisone equivalents if other etiologies are ruled out and corticosteroids are being used for immune-mediated nephritis 5
The International Society of Nephrology suggests immediate nephrology consultation and administering corticosteroids at 1-2 mg/kg/day prednisone equivalent for Grade 3 creatinine elevation 5

The American Society of Nephrology recommends considering cyclosporin ± low-dose corticosteroid as alternative therapy for glomerular diseases with deteriorating renal function over 2-3 months and proteinuria >8 g/day 6
The National Kidney Foundation suggests avoiding immunosuppressive therapy unless there is crescentic disease with rapidly deteriorating function in patients with GFR <30 mL/min/1.73 m² 7

The American College of Cardiology warns against combining corticosteroids with NSAIDs in patients with any degree of renal impairment, as this can significantly impair renal function 2, 3, 4
The American Society of Clinical Oncology advises against reflexively reducing corticosteroid doses based solely on elevated creatinine if treating immune-mediated nephritis, as adequate immunosuppression may be necessary to reverse the underlying process 5

The European Society of Cardiology recommends optimizing blood pressure control with ACE inhibitors or ARBs if not contraindicated, targeting BP <120/75 mmHg in proteinuric patients 6
The American Society of Nephrology suggests avoiding diuretics for at least 24 hours after any nephrotoxic agent exposure, and monitoring for hyperkalemia, particularly if using ACE inhibitors/ARBs 3, 4
The National Kidney Foundation recommends considering calcium supplementation, as all corticosteroids increase calcium excretion, which may be particularly problematic in CKD patients with disturbed calcium metabolism 1